Next Quarterly Earnings
Wednesday, August 5, 2026
CW 32
After-Hours
In 31 days
Sarepta Therapeutics
Sarepta Therapeutics is a leading US-based biotechnology company focused on developing and commercializing innovative gene therapies and RNA-based medicines. The company's primary focus is on rare neuromuscular diseases, such as Duchenne muscular dystrophy, aiming to improve the lives of patients globally.
All Dates
Earnings history data not available
Company Information
Name
Sarepta Therapeutics
Country
🇺🇸
More Financial Information